Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock - $0.01 Par Value
-
Shares outstanding
-
46,382,189
-
Number of holders
-
267
-
Total 13F shares, excl. options
-
44,367,274
-
Shares change
-
+353,371
-
Total reported value, excl. options
-
$1,134,245,375
-
Value change
-
+$6,577,133
-
Put/Call ratio
-
15%
-
Number of buys
-
95
-
Number of sells
-
-129
-
Price
-
$25.56
Significant Holders of AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (AVNS) as of Q2 2023
308 filings reported holding AVNS - AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value as of Q2 2023.
AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (AVNS) has 267 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 44,367,274 shares
of 46,382,189 outstanding shares and own 96% of the company stock.
Largest 10 shareholders include BlackRock Inc. (7,298,104 shares), VANGUARD GROUP INC (5,472,322 shares), DIMENSIONAL FUND ADVISORS LP (3,118,152 shares), RGM Capital, LLC (2,762,674 shares), Paradice Investment Management LLC (2,244,435 shares), STATE STREET CORP (2,047,319 shares), MACQUARIE GROUP LTD (1,967,590 shares), WESTWOOD HOLDINGS GROUP INC (1,715,039 shares), T. Rowe Price Investment Management, Inc. (1,509,182 shares), and GOLDMAN SACHS GROUP INC (960,942 shares).
This table shows the top 267 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.